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Abstract
Background: Liver-to-pancreas conversion offers new possibilities for β-cell engineering for type
1 diabetes therapy. Among conceivable sources of liver cells, we focused on BMEL cells. These
untransformed mouse embryonic liver cells have been reproducibly isolated from different inbred
mice strains and have the potential to differentiate into hepatocytes and cholangiocytes in vitro and
in vivo.
Findings: Strikingly, we find here that adherent BMEL cells display functional similarities with
multipotent pancreatic precursor cells, namely Pdx1 and Ngn3 expression, and further express
Hnf6 in floating aggregate culture. Hes1, a direct repressor of Ngn3 and pancreatic endocrine
commitment, is expressed in adherent BMEL cells and decreases with time in aggregate culture.
However, Hes1 decrease fails to initiate activation of late-stage pancreatic endocrine transcription
factors.
Conclusion: Here we report that BMEL cells present features of pancreatic endocrine progenitor
cells. In the field of diabetes research, BMEL cells are of potential interest for the study of inductive
signals critical for in vitro β-cell maturation in-liver-to-pancreas conversion.
Background
Diabetes results from the autoimmune destruction of
pancreatic  β-cells. The last years have witnessed major
advances in engineering renewable supplies of β-cells
through a combination of extrinsic cues and intrinsic
reprogramming of hepatic stem cells. During embryogen-
esis, liver and pancreas arise from adjacent regions of the
anterior foregut endoderm [1] and mutual plasticity
between the liver and pancreas in the adult occurs in var-
ious pathological and experimental settings [2]. Lineage
tracing studies have defined pancreatic master genes
determining specification and maturation of the pancre-
atic endocrine cell lineage, namely pancreatic and duode-
nal homeobox-1 protein (Pdx1), bHLH proteins
pancreatic transcription factor 1a (Ptf1a/P48) and neuro-
genin 3 (Ngn3) [3,4]. Conversely, loss of function and
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misexpression experiments demonstrate that the Notch
pathway plays a pivotal role in pancreatogenesis as it
maintains an undifferentiated progenitor population.
Hairy enhancer and split 1 (Hes1) acts as a key down-
stream effector of the Notch pathway by repressing pan-
creatic endocrine cell specification via direct Ngn3 down-
regulation [5]. Hes1 repression promotes conversion of
biliary cells to pancreatic cells in developing tissues [6].
Although earlier findings demonstrate the feasibility of in
vitro and in vivo liver-to-pancreas conversion [7], appro-
priate allo- or autologuous cell sources need to be charac-
terised. Bipotential mouse embryonic liver cells have been
reproducibly isolated from mouse embryos of different
strains. BMEL cells have the potential to differentiate into
hepatocytes and cholangiocytes in specific 3-D culture
systems in vitro or after engraftment in damaged livers in
Alb-uPA/SCID mice in vivo [8]. In the present study, we
seek for the expression of pancreatic progenitor markers
and Hes1 expression in BMEL stem cells in different cul-
ture modes.
Methods
Adherent BMEL cell culture
BMEL 9A1 cells, kindly provided by M. Weiss [8], were
grown in RPMI 1640 (Invitrogen, Cergy-Potoise, France)
supplemented with 10% foetal calf serum (Eurobio, Les
Ulis, France), 50 ng/ml Epidermal Growth Factor (Pepro-
Tech, Levallois Perret, France), 30 ng/ml Insulin-like
Growth Factor II (PeproTech), and 10 μg/ml human insu-
lin (Roche, Meylan, France). Cells were cultured on dishes
coated with Collagen I (Becton-Dickinson, Le Pont de
Claix, France) in a humidified 5% CO2 atmosphere at
37°C. Cells were passaged every 3 to 4 days at 70.103 cells
for a 100 mm dish, and never let sit at confluence.
Aggregate BMEL cell culture
1,5.103 cells per well were seeded onto 96-well plates
coated with Collagen I and cultured for two days as indi-
cated previously. Cells were then dissociated with trypsin-
EDTA (Eurobio) and 1.104 cells per well were seeded into
96-wells coated with poly(2-hydroxyethyl-methacrylate)
(Sigma-Aldrich, Saint Quentin Fallavier, France) to which
cells do not attach, but form floating aggregates within 24
hours. Aggregates were collected for analysis 4 days after
seeding.
mRNA isolation and RT-PCR reactions
mRNA was isolated with the Dynabeads mRNA Direct Kit
(Invitrogen). First-strand cDNA was synthesized using M-
MuLV reverse transcriptase (Promega, Charbonnières,
France) and 400 nM random pentadecamer primers
(Eurogentec, Liège, Belgique) [9]. cDNA was amplified by
PCR over 35 cycles [94°C for 30 sec, 59 or 60°C for 30 sec,
and 72°C for 40 sec] with RedTaq DNA Polymerase
(Sigma-Aldrich) on a 9700 thermocycler (Applied Biosys-
tems, Courtaboeuf, France) using the following primer
pairs: β-actin (forward) 5'-AGCCATGTACGTAGCCATCC-
3' (reverse) 5'-CTCTCAGCTGTGGTGGTGAA-3'; hnf6 (for-
ward) 5'-CTGTGAAACTCCCCCAGGTA-3' (reverse) 5'-
TCATCCCGCATAAGTGTGAA-3';  ngn3  (forward) 5'-
GAGTTGGCACTCAGCAAACA-3' (reverse) 5'-TCTGAGT-
CAGTGCCCAGATG-3'; pdx1 (forward) 5'-CTGCGAGCT-
TCTGGAAAAAC-3' (reverse) 5'-
CTGCTGGTCCGTATTGGAAC-3';  neuroD  (forward) 5'-
GAAAGCCCCCTAACTGACTGC-3' (reverse) 5'-
GCACTTTGCAGCAATCTTAGCAAAA-3'; nkx2.2 (forward)
5'-GGTGGAGCGATTGGATAAGA-3' (reverse) 5'-
TGCCATCAACCTTTTCATCA-3'; nkx6.1 (forward) 5'-AGT-
GATGCAGAGTCCGCCG (reverse) TCCTCATTCTC-
CGAAGTC-3';  hes1  (forward) 5'-
CCTCTGAGCACAGAAAGTCATC-3' (reverse) 5'-TCCA-
GAATGTCTGCCTTCTC-3';  insulin1  (forward) 5'-CAT-
CAGCAAGCAGGTYATTG-3' (reverse) 5'-
CACTTGTGGGTCCTCCACTT-3';  insulin2  (forward) 5'-
AGGACCCACAAGTGGCACA-3' (reverse) 5'-GAGGGG-
TAGGCTGGGTAGTG-3'; ptf1a (forward) 5'-GTAACCAG-
GCCCAGAAGGT-3' (reverse) 5'-
CCTCTGGGGTCCACACTTTA-3';  amylase  (forward) 5'-
GGCCTTCTGGATCTTGCAC-3' (reverse) 5'-TCCTT-
GGGAGAACCATTTTG-3'.
Quantitative real-time RT-PCR was performed on 1 μl of
cDNA with Prism 5700 sequence-detection system
(Applied Biosystems). Cycling parameters were initiation
at 50°C for 2 min and denaturation at 95°C for 10 min
followed by 40 cycles of denaturation 95°C for 15 sec and
annealing at 60°C for 1 min. Mouse hes1 (D16464) and
β-actin  (NM_007393) expression were amplified using
300 nM hes1 (forward) CCTCTGAGCACAGAAAGTCATC
(reverse) GCATCCAAAATCAGTGTTTTCA, and β-actin
(forward) CTCTTCCAGCCTTCCTTCCT (reverse)
GGGCAGTGATCTCTTTCTGC primers in Power Sybr
Green Master Mixture (Applied Biosystems), Relative real
time PCR data were processed according to a standard
curve based method [10] generating reference gene nor-
malized expression values. Statistical comparisons
between groups of treated versus untreated samples were
performed using a non parametric Mann-Withney test.
Immunocytochemistry
Ngn3, Pdx1, and Hes1 immunostaining was carried out
on cytospins of 40,000 BMEL cells after 4 days of adherent
or suspension culture. Cells were fixed in 4% paraformal-
dehyde, permeabilized in PBS-Triton X-100 0,2%, and
blocked in BPS, 1%BSA, 10% goat serum before incuba-
tion with primary antibodies in PBS -1% BSA. Primary
antibodies used were: rabbit anti-Pdx1(1:3000), a gift
from C. Wright, rabbit anti-Ngn3 (1:3000), a gift from M.
German, and rabbit anti-Hes1 (1:60), a gift from T. Sudo.
Secondary biotinylated goat anti-rabbit Ig antibodyBMC Research Notes 2008, 1:136 http://www.biomedcentral.com/1756-0500/1/136
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(Dako E0432) was used at 1:300 and detected with
streptavidine-conjugated HRP (Dako, P397) and DAB
substrate (Dako, SK-4100).
Western blotting
After harvest with trypsin-EDTA, cells were washed with
D-PBS and lysed in RIPA lysis buffer (Upstate, Eurome-
dex, Mundolsheim, France) supplemented with protease
inhibitors (Sigma-Aldrich, P8340). 50 μg of protein
extract were fractionated by 8% SDS-PAGE and trans-
ferred to PVDF membrane (BioRAD, Marnes la Coquette,
France). After blocking at room temperature for 2 h in TBS
with 5% nonfat dry milk, the membranes were incubated
for 1 h in TTBS containing 0,6 μg/ml polyclonal rabbit
anti-mouse Hes1 antibody (kindly provided by T. Sudo)
or polyclonal goat anti-mouse Pdx1 antibody (1:10000,
kindly provided by C.V.E. Wright), and then for 1 h with
TTBS containing secondary anti-rabbit (1:10000, Pierce,
Perbio, Brebières, France) or anti-goat (1:10000, Dako)
conjugates coupled to HRP. Antibody binding was visual-
ized by ECL using Supersignal West Pico substrate
(Pierce). Blots were stripped by 5 min incubation in 0,2 M
NaOH, blocked for 1 h in TBS with 5% nonfat dry milk,
and re-probed for 2 h in TTBS with primary anti-β-actin
antibody (1:200, TEBU, Santa-Cruz) coupled to HRP.
Anti-β-actin antibody binding was detected using ECL
substrate as stated before. Band intensities were measured
on a Chemidoc XRS system (BioRAD) and relative abun-
dance of Hes1 protein normalized to β-actin was assessed
by densitometry using Quantity One software (BioRAD).
Results
Characteristics of BMEL cells
BMEL cells can be propagated in an undifferentiated state
in adherent culture on collagen-coated dishes. Here, we
investigated pancreatic gene expression in BMEL cells after
4 days of culture. Adherent BMEL cells spontaneously
expressed transcripts and protein of Pdx1 (Fig. 1), a
regional endodermal marker found in pancreatic buds, at
the origin of all pancreatic lineages [11,12]. Immunos-
taining also revealed a subpopulation of cells expressing
Ngn3, which is considered to be the earliest marker spe-
cific to the endocrine lineage [4]. However, RT-PCR failed
to detect ngn3 at the transcript level. At this stage, BMEL
cells were devoid of Ptf1a and other markers of more
advanced pancreatic commitment or mature β-cells. Sus-
pension culture induced formation of floating aggregates
and concurrent expression of hepatocyte nuclear factor 6
(hnf6), a factor known to activate ngn3 expression and to
control the timing of the pancreas specification upstream
of Pdx1 [13]. Ngn3 became detectable in 3 out of 5 sam-
ples at the transcript level and Ngn3 protein was present
in a great majority of cells analysed by immuncytochem-
istry. Hairy enhancer and split 1 (hes1), a direct repressor
of the ngn3 promoter, was detected by qualitative end-
point RT-PCR in all samples regardless of culture mode
even though immunocytochemistry experiments yielded
less intense staining in cells of aggregate cultures.
Hes1 expression decreased with time in BMEL aggregates
BMEL cells were grown for 1 or 4 days in aggregate culture
and analyzed by Western blotting and real-time RT-qPCR.
Sustained Hes1 expression at day 1 was nearly abolished
at day 4 in aggregate culture with a good correspondence
between the level of suppression at the protein and RNA
levels (Fig. 2).
Discussion
Liver-to-pancreas conversion offers new possibilities for
β-cell engineering for cell therapy of diabetes [14]. Here
we focus on untransformed BMEL cells, a new model of
bipotential liver progenitor cells that have been reproduc-
ibly isolated from different inbred mice strains at 14 dpc.
In adherent culture, these cells propagate with a high pro-
liferation index in an undifferentiated state [8]. Strikingly,
adherent BMEL cells in our hands also display functional
similarities with multipotent pancreatic precursor cells,
namely Pdx1 and Ngn3 expression, which does not occur
in embryonic liver development. Indeed, Pdx1 is thought
to act as a master regulatory gene, sufficient per se to dis-
tinguish liver and pancreas in normal development. No
spontaneous Pdx1 expression in the hepatic lineage has
been described yet during embryogenesis or in the adult
liver in the absence of high glucose concentrations [15].
Western blot analysis reveals a 46 kDa endogenous Pdx1
protein, which is in accordance with the apparent weight
of the active phosphorylated form of Pdx1 in earlier find-
ings [16]. Ngn3, a true marker of endocrine commitment
[4,17] is detected at the protein, but not at the transcript
level in adherent cells. This apparent discrepancy may
stem either from differences in the sensitivity of the tech-
niques used here or from a greater stability of the protein.
Following aggregate formation, BMEL cells further express
Hnf6, and Ngn3 becomes detectable at the transcript as
well as the protein level. These results fit with the idea that
BMEL cells do not closely phenocopy bipotential hepato-
blasts in vivo, and may present an enlarged differentiation
potential. Immunocytochemistry results presented in Fig.
1 show that most BMEL cells evenly express Pdx1 and
Ngn3 ruling out the idea that pancreatic progenitor-like
cells form a sparse subpopulation. It is noteworthy that
Ngn3-positive cells have a limited mitotic potential [18],
opening the possibility for rapid overgrowth by less differ-
entiated cells in culture. Apart from Pdx1, Hnf6, and
Ngn3, BMEL cells do not express any of the downstream
effectors of more advanced pancreatic commitment.
Moreover, expression of pancreatic markers in aggregates
remains unchanged following culture in high glucose
medium, which is known to stimulate maturation of pan-
creatic progenitors (25 mM glucose, data not shown) [19].BMC Research Notes 2008, 1:136 http://www.biomedcentral.com/1756-0500/1/136
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Hes1, a direct repressor of Ngn3, is expressed in BMEL
cells regardless of culture conditions, albeit quantitative
real-time PCR shows a decrease with time in aggregate cul-
ture. Although Hes1 is expressed in intrahepatic bile duct
cells at the neonatal stage, it is usually absent in hepatob-
lasts [20]. On the other hand, Hes1 is present in pancre-
atic progenitor cells where it acts as a dominant factor
promoting self-renewal at the expense of β-cell differenti-
ation [21]. Previous microarray data suggest that Notch
signalling pathway is operative in maintaining BMEL cells
in an undifferentiated state [22]. However, notch signal-
ling disruption experiments failed to initiate activation of
late-stage pancreatic transcription factors in BMEL aggre-
gates (Additional_data_1). These results support the idea
that factors beyond Hes1 expression, presumably the
absence of Ptf1a, impede the extent of expression of Ngn3
and other factors of more advanced β-cell differentiation
[23-25]. Indeed, lineage-tracing experiments have shown
that endocrine i.e. Ngn3-positive cells derive from pro-
genitors that express Ptf1a and, henceforth, Ngn3 and
Ptf1a are usually co-expressed in pancreatic multipotent
progenitors [3,23]. To summarize, here we report that
BMEL characteristics in adherent vs aggregate culture Figure 1
BMEL characteristics in adherent vs aggregate culture. (A) Morphology of BMEL cells grown for 4 days in (i) adherent 
or (ii) floating aggregate culture. (B) Western blot analysis of BMEL cells after four days of adherent or aggregate culture show-
ing the expression of a 46kDa Pdx1 protein (n = 3). (C) RT-PCR profiles of adherent (Adh.) or aggregate (Agg) BMEL cells (n = 
5). * Three out of five aggregate samples yielded positive ngn3 RT-PCR signals. cDNA from adult mouse pancreas (Panc) 
served as positive control for all genes except for Ngn3 for which a plasmid containing the ngn3 open reading frame was used 
as positive control. (D) Spontaneous Pdx1, Ngn3, and Hes1 expression located predominantly in the nuclei of adherent (top 
row) or aggregate (bottom row) BMEL cells. Scale bars = 40 μm.BMC Research Notes 2008, 1:136 http://www.biomedcentral.com/1756-0500/1/136
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BMEL cells display two stage-specific features of multipo-
tent pancreatic progenitor cells, namely Pdx1 and Ngn3
expression. In the field of β-cell replacement research,
BMEL cells are of potential interest for the study of induc-
tive signals critical for β-cell maturation including positive
selection of cells, trophic factors, or ectopic expression of
pancreatic transcription factors like Ptf1a in complement
to endogenous Pdx1 and Ngn3 expression.
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